In vivo dosimetry in external beam photon radiotherapy: Requirements and future directions for research, development, and clinical practice

External beam radiotherapy with photon beams is a highly accurate treatment modality, but requires extensive quality assurance programs to confirm that radiation therapy will be or was administered appropriately. In vivo dosimetry (IVD) is an essential element of modern radiation therapy because it...

Full description

Saved in:

Bibliographic Details
Published in:	Physics and imaging in radiation oncology Vol. 15; pp. 108 - 116
Main Authors:	Olaciregui-Ruiz, Igor, Beddar, Sam, Greer, Peter, Jornet, Nuria, McCurdy, Boyd, Paiva-Fonseca, Gabriel, Mijnheer, Ben, Verhaegen, Frank
Format:	Journal Article
Language:	English
Published:	Netherlands Elsevier B.V 01.07.2020 Elsevier
Subjects:	Electronic portal imaging device External beam radiotherapy In vivo dosimetry Review Task group report Electronic portal imaging device External beam radiotherapy Review In vivo dosimetry Task group report
ISSN:	2405-6316, 2405-6316
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!

Description
Summary:	External beam radiotherapy with photon beams is a highly accurate treatment modality, but requires extensive quality assurance programs to confirm that radiation therapy will be or was administered appropriately. In vivo dosimetry (IVD) is an essential element of modern radiation therapy because it provides the ability to catch treatment delivery errors, assist in treatment adaptation, and record the actual dose delivered to the patient. However, for various reasons, its clinical implementation has been slow and limited. The purpose of this report is to stimulate the wider use of IVD for external beam radiotherapy, and in particular of systems using electronic portal imaging devices (EPIDs). After documenting the current IVD methods, this report provides detailed software, hardware and system requirements for in vivo EPID dosimetry systems in order to help in bridging the current vendor-user gap. The report also outlines directions for further development and research. In vivo EPID dosimetry vendors, in collaboration with users across multiple institutions, are requested to improve the understanding and reduce the uncertainties of the system and to help in the determination of optimal action limits for error detection. Finally, the report recommends that automation of all aspects of IVD is needed to help facilitate clinical adoption, including automation of image acquisition, analysis, result interpretation, and reporting/documentation. With the guidance of this report, it is hoped that widespread clinical use of IVD will be significantly accelerated.
Bibliography:	ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 ObjectType-Review-3 content type line 23
ISSN:	2405-6316 2405-6316
DOI:	10.1016/j.phro.2020.08.003